Schedule 13G ownership disclosure

KALARIS THERAPEUTICS INC

Common Stock · CUSIP: 482929106

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLC

    Shares: 201,718.00 · Class: 1.1%

  • Oleg Nodelman

    Shares: 201,718.00 · Class: 1.1%

  • EcoR1 Capital Fund Qualified, L.P.

    Shares: 191,242.00 · Class: 1.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000363
Form type
SCHEDULE 13G/A
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub